A detailed history of Clari Vest Asset Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 14,469 shares of SRPT stock, worth $1.59 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
14,469
Previous 14,469 -0.0%
Holding current value
$1.59 Million
Previous $2.29 Million 20.95%
% of portfolio
0.18%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$113.33 - $163.85 $4,419 - $6,390
39 Added 0.27%
14,469 $2.29 Million
Q1 2024

May 06, 2024

SELL
$93.7 - $141.53 $12,087 - $18,257
-129 Reduced 0.89%
14,430 $1.87 Million
Q4 2023

Feb 13, 2024

SELL
$67.31 - $124.76 $807 - $1,497
-12 Reduced 0.08%
14,559 $1.4 Million
Q3 2023

Nov 13, 2023

BUY
$102.5 - $123.59 $2,152 - $2,595
21 Added 0.14%
14,571 $1.77 Million
Q2 2023

Aug 14, 2023

SELL
$106.4 - $157.19 $319,625 - $472,198
-3,004 Reduced 17.11%
14,550 $1.67 Million
Q1 2023

May 08, 2023

SELL
$117.53 - $155.99 $1,998 - $2,651
-17 Reduced 0.1%
17,554 $2.42 Million
Q4 2022

Feb 14, 2023

SELL
$100.86 - $132.13 $6,959 - $9,116
-69 Reduced 0.39%
17,571 $2.28 Million
Q3 2022

Nov 10, 2022

BUY
$75.71 - $119.24 $1.34 Million - $2.1 Million
17,640 New
17,640 $1.95 Million
Q3 2021

Nov 08, 2021

SELL
$65.97 - $92.48 $705,879 - $989,536
-10,700 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$72.25 - $168.95 $7,225 - $16,895
-100 Reduced 0.93%
10,700 $798,000
Q4 2020

Feb 09, 2021

SELL
$125.56 - $178.74 $50,224 - $71,496
-400 Reduced 3.57%
10,800 $1.84 Million
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $1.04 Million - $1.92 Million
11,200 New
11,200 $1.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.62B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.